Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
ipilimumab nivolumab | 1.58 | 0.9 | 5029 | 2 | 22 |
ipilimumab | 0.04 | 1 | 1254 | 71 | 10 |
1.44 | 0.4 | 9291 | 74 | 1 | |
nivolumab | 1.08 | 0.2 | 739 | 30 | 9 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
ipilimumab nivolumab | 1.88 | 0.4 | 5199 | 24 |
ipilimumab nivolumab melanoma | 1.5 | 0.5 | 5167 | 17 |
ipilimumab nivolumab mesothelioma | 0.33 | 1 | 139 | 47 |
ipilimumab nivolumab hcc | 0.56 | 0.5 | 2325 | 61 |
ipilimumab nivolumab nebenwirkungen | 0.72 | 0.8 | 6555 | 24 |
ipilimumab nivolumab renal cell carcinoma | 1.02 | 0.1 | 3383 | 25 |
ipilimumab nivolumab bijwerkingen | 1.38 | 0.8 | 4151 | 58 |
ipilimumab nivolumab nsclc | 0.81 | 0.3 | 1622 | 61 |
ipilimumab nivolumab fachinfo | 1.38 | 0.5 | 5660 | 85 |
ipilimumab nivolumab dosierung | 0.57 | 0.4 | 781 | 54 |
ipilimumab nivolumab rcc | 0.19 | 1 | 3918 | 99 |
ipilimumab nivolumab cco | 1.09 | 0.4 | 9686 | 17 |
ipilimumab nivolumab nccp | 1.24 | 0.4 | 7139 | 23 |
ipilimumab nivolumab cabozantinib sarcoma | 0.17 | 0.2 | 5230 | 100 |
ipilimumab nivolumab checkpoint inhibitors | 1.98 | 0.1 | 5827 | 48 |
ipilimumab and nivolumab | 0.56 | 0.2 | 3519 | 51 |
side effects of ipilimumab and nivolumab | 0.95 | 0.1 | 5332 | 44 |
nivolumab combined with ipilimumab | 0.21 | 0.3 | 9565 | 46 |
ipilimumab and nivolumab melanoma | 1.19 | 0.8 | 4847 | 90 |
nivolumab and ipilimumab therapy | 0.5 | 0.5 | 673 | 86 |